Effects of Recombinant Erythropoietin on Breast Cancer-Initiating Cells

BACKGROUND: Cancer anemia causes fatigue and correlates with poor treatment outcome. Erythropoietin has been introduced in an attempt to correct these defects. However, five recent clinical trials reported a negative impact of erythropoietin on survival and/or tumor control, indicating that experime...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Phillips, Tiffany M, Kim, Kwanghee, Vlashi, Erina, McBride, William H, Pajonk, Frank
Формат: Artigo
Язык:Inglês
Опубликовано: Neoplasia Press Inc. 2007
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2134908/
https://ncbi.nlm.nih.gov/pubmed/18084619
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы